PEP on a Skin Graft Donor Site Wound
Status unconfirmed · Phase 1
Conditions studied: Skin Graft
In brief
The purpose of this study is to determine the safety of a biological therapeutic PEP in participants who have skin graft donor site wounds.
Key facts
- Study ID
- NCT04664738
- Run by
- Rion Inc.
- People needed
- 8
- Starts
- 2021-03-16
- Expected to finish
- 2024-02-02
- Last updated by the study team
- 2023-09-08
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- International Research Partners — Doral, Florida, United States
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.